Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Commonwealth Associates is a New York-based investment banking and venture capital firm that has historically played a significant role in the financing and development of the life sciences and biotechnology sectors. Founded by Michael Goldberg, the firm specializes in providing capital raising, strategic advisory, and merchant banking services to emerging growth companies, particularly in healthcare and technology. Commonwealth Associates is well-known for its involvement in the early-stage funding and initial public offerings of several prominent biotech companies, including CombiChem, Discovery Partners International, and Cypress Bioscience. While not a drug developer itself, the firm acts as a critical financial architect within the biotech ecosystem, facilitating the transition of scientific innovations from private research to public markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Commonwealth Associates.